Perceived cognitive function and related factors in Korean women with breast cancer

Asian Nursing Research

Volumn 5, Issue 2, 2011, Pages 141-150

  Moon, Seongmi ^a   Kim, Sun Hee ^b   Kim, Mi Ja ^c  

^a University of Ulsan College of Medicine   (South Korea)

^b Seoul Women College of Nursing   (South Korea)

^c Ulsan University College of Medicine   (South Korea)

Author keywords

attention; breast neoplasms; cognition

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; PACLITAXEL; TRASTUZUMAB;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; COGNITION; FEMALE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MOOD DISORDER; PRIORITY JOURNAL; RATING SCALE; SELF EVALUATION;

EID: 79960209503     PISSN: 19761317     EISSN: 20937482     Source Type: Journal    
DOI: 10.1016/S1976-1317(11)60022-4     Document Type: Article

References (32)

1. T.A. Ahles, A.J. Saykin Candidate mechanisms for chemotherapy-induced cognitive changes Nature Reviews Cancer 7 2007 192 201
2. C. Anderson-Hanley, M.L. Sherman, R. Riggs, V.B. Agocha, B.E. Compás Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature Journal of International Neuropsychological Society 9 2003 967 982 (Pubitemid 37428441)
3. S.A. Castellón, R.A. Ganz, J.E. Bower, L. Petersen, L. Abraham, G.A. Greendale Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen Journal of Clinical and Experimental Neuropsychology 26 2004 955 969 (Pubitemid 39577316)
4. B. Cimprich Attentional fatigue following breast cancer surgery Research in Nursing and Health 15 1992 199 207
5. B. Cimprich Development of an intervention to restore attention in cancer patients Cancer Nursing 26 1993 83 92 (Pubitemid 23119156)
6. B. Cimprich Premature symptom distress in women newly diagnosed with breast cancer Cancer Nursing 22 1999 185 194 (Pubitemid 29354720)
7. B. Cimprich, H. So, D.L. Ronis, C. Trask Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer Psycho-Oncology 14 2005 70 78 (Pubitemid 40124675)
8. B. Cimprich, M. Visovatti, D.L. Ronis The attentional function index-a self-report cognitive measure Psycho-Oncology 20 2011 194 202
9. J. Debess, J.O. Riis, M.C. Engebjerg, M. Ewertz Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study Breast Cancer Research and Treatment 121 2010 91 100
10. S. Deprez, E. Amant, R. Yigit, K. Porke, J. Verhoeven, I. Van den Stock et al. Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients Human Brain Mapping 32 2011 4802n B.
11. M.G. Falleti, A. Sanfilippo, P. Maruff, L. Weih, K.A. Phillips The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature Brain and Cognition 59 2005 50 60
12. Health Insurance Review & Assessment Service Prevalence and hospital cost of breast cancer Retrieved May 4, 2011, from http://stat.mw.go.kr/stat/ data/cm-data-view.jsp?menu-code=MN03020000&cont-seq=16145 2010
13. K. Hermelink, M. Untch, M.P. Lux, R. Kreienberg, T. Beck, I. Bauerfeind et al. Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study Cancer 109 2007 1905 1913 (Pubitemid 46668557)
14. K. Hermelink, H. Küchenhoff, M. Untch, I. Bauerfeind, M.P. Lux, M. Buhner et al. Two different sides of'chemobrain': determinants and nondetermi-nants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study Psycho-Oncology 19 2010 1321 1328
15. C.E. Jansen, B.A. Cooper, M.I. Dood, C.A. Miaskowski A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients Supportive Care in Cancer 2010 10.1007/s00520-010-0997-4
16. C.E. Jansen, C. Miaskowski, M. Dodd, G. Dowling, J. Kramer A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function Cancer 104 2005 2222 2233 (Pubitemid 41579970)
17. V. Jenkins, V. Shilling, L. Fallowfield, A. Howell, S. Hutton Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study Psycho-Oncology 13 2004 61 66 (Pubitemid 38139358)
18. H.S. Jim, K.A. Donovan, B.I. Small, M.A. Andrykowski, P.N. Munster, P.B. Jacobsen Cognitive functioning in breast cancer survivors: a controlled comparison Cancer 115 2009 1776 1783
19. Kim, S. H. (2006). Effects of an individualized exercise program on cancer-related fatigue, physical and cognitive function, and emotional status in patients with gastric cancer during chemotherapy. Unpublished doctoral dissertation, Yonsei University, Seoul, Korea.
20. M. Mehlsen, A.D. Pedersen, A.B. Jensen, R. Zachariae No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy Psycho-Oncology 18 2009 248 257
21. A. Mehnert, A. Scherwath, L. Schirmer, G. Petersen, E. Schulz-Kindermann, A.R. Zander et al. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy Patient Education and Counseling 66 2007 108 118 (Pubitemid 46366616)
22. National Cancer Information Center Cancer Survival Rate (1993-2008) Retrieved from May 4, 2011, http://www.cancer.go.kr/cms/statics/survival-rate/ index.html 2010
23. A. Paganini-Hill, L.J. Clark Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen Breast Cancer Research and Treatment 64 2000 165 176 (Pubitemid 32010334)
24. C. Quesnel, J. Savard, H. Ivers Cognitive impairments association with breast cancer treatments: results from a longitudinal study Breast Cancer Research and Treatment 116 2009 113 123
25. D.H. Silverman, C.J. Dy, S.A. Castellón, J. Lai, B.S. Pio, L. Abraham et al. Altered frontocortical, cerebella, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy Breast Cancer Research and Treatment 103 2007 303 311 (Pubitemid 46944511)
26. A. Stewart, C. Bielajew, B. Collins, M. Parkinson, E. Tomiak A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer The Clinical Neuropsychologist 20 2006 76 89
27. H.J. Sutherland, R. Walker, J.E. Till The development of a method for determining oncology patients' emotional distress using linear analogue scales Cancer Nursing 11 1988 303 308
28. F.S. van Dam, S.B. Schagen, M.J. Muller, W. Boogerd, E. vd Wall, M.E. Droogleever Fortuyn et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high dose versus standard-dose chemotherapy Journal of National Cancer Institute 90 1998 210 218 (Pubitemid 28114539)
29. K.J. Vearncombe, M. Rolfe, M. Wright, M. Wright, N.A. Pachana, B. Andrew et al. Predictors of cognitive decline after chemotherapy in breast cancer patients Journal of the International Neuropsychologi-cal Society 15 2009 951 962
30. C.C. Verstappen, J.J. Heimans, K. Hoekman, T.J. Postma Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optima management Drugs 63 2003 1549 1563 (Pubitemid 36976138)
31. J.S. Wefel, R. Lenzi, R.L. Theriault, R.N. Davis, C.A. Meyers The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial Cancer 100 2004 2292 2299 (Pubitemid 38657875)
32. J.S. Wefel, I. Vardy, T. Ahles, S.B. Schagen International cognition and cancer tast force recommendations to harmonise studies of cognitive function in patients with cancer The Lancet Oncology 2011 10.1016/S0140-6736(08)61345-8